The article Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/−52 Studies written by Martin Desrosiers, Scott Nash, Andrew Lane, Stella E. Lee, Eugenio De Corso, Changming Xia, Mark Corbett, Amr Radwan, Paul J. Rowe and Yamo Deniz was originally published electronically on the publisher’s internet portal on September 27, 2025 without open access. After publication in volume 42, issue 12, pages 5980–5993, the author requested that the article be Open Choice to make the article an open access publication. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. In this article, reference 2 was published as “Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2021;141:27–34”, it will be updated as ’Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2021;14:127–34”. Reference 21 was published as “Bachert C, Khan AH, Hopkins C, et al. Rapid and continuing improvements in nasal symptoms with dupilumab in patients with severe CRSwNP. J Asthma Allergy. 2022;4(15):557–63”, it will be updated as Bachert C, Khan AH, Hopkins C, et al. Rapid and continuing improvements in nasal symptoms with dupilumab in patients with severe CRSwNP. J Asthma Allergy. 2022;15:557–63”. The original article has been corrected.
Correction to: Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 Studies (Advances in Therapy, (2025), 42, 12, (5980-5993), 10.1007/s12325-025-03378-2)
De Corso E.;
2025
Abstract
The article Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/−52 Studies written by Martin Desrosiers, Scott Nash, Andrew Lane, Stella E. Lee, Eugenio De Corso, Changming Xia, Mark Corbett, Amr Radwan, Paul J. Rowe and Yamo Deniz was originally published electronically on the publisher’s internet portal on September 27, 2025 without open access. After publication in volume 42, issue 12, pages 5980–5993, the author requested that the article be Open Choice to make the article an open access publication. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. In this article, reference 2 was published as “Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2021;141:27–34”, it will be updated as ’Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2021;14:127–34”. Reference 21 was published as “Bachert C, Khan AH, Hopkins C, et al. Rapid and continuing improvements in nasal symptoms with dupilumab in patients with severe CRSwNP. J Asthma Allergy. 2022;4(15):557–63”, it will be updated as Bachert C, Khan AH, Hopkins C, et al. Rapid and continuing improvements in nasal symptoms with dupilumab in patients with severe CRSwNP. J Asthma Allergy. 2022;15:557–63”. The original article has been corrected.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
